Pantoprazole: A review of its pharmacological properties and therapeutic use in acid-related disorders (vol 51, pg 460, 1996)

被引：1

|

作者：

Fitton, A

Pantoprazole, WL

机构：

来源：

DRUGS | 1996年 / 52卷 / 01期

关键词：

D O I：

10.1007/BF03259131

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：92 / 92

页数：1

相关论文

共 50 条

[21] RabeprazoleAn Update of its Use in Acid-Related Disorders
Christopher I. Carswell
Karen L. Goa
Drugs, 2001, 61 : 2327 - 2356
[22] LANSOPRAZOLE - A REAPPRAISAL OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND ITS THERAPEUTIC EFFICACY IN ACID-RELATED DISORDERS
SPENCER, CM
FAULDS, D
DRUGS, 1994, 48 (03) : 404 - 430
[23] CHENODEOXYCHOLIC ACID - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE
ISER, JH
SALI, A
DRUGS, 1981, 21 (02) : 90 - 119
[24] PERINDOPRIL - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN CARDIOVASCULAR DISORDERS
TODD, PA
FITTON, A
DRUGS, 1991, 42 (01) : 90 - 114
[25] Epoetin beta: A review of its pharmacological properties and clinical use in the management of anaemia associated with chronic renal failure (vol 51, pg 314, 1996)
Dunn, CJ
Markham, A
DRUGS, 1996, 51 (05) : 894 - 894
[26] RANITIDINE - A PHARMACOECONOMIC EVALUATION OF ITS USE IN ACID-RELATED DISORDERS
FRAMPTON, JE
MCTAVISH, D
PHARMACOECONOMICS, 1994, 6 (01) : 57 - 89
[27] A review of omeprazole use in the treatment of acid-related disorders in children
Zimmermann, AE
Walters, JK
Katona, BG
Souney, PF
Levine, D
CLINICAL THERAPEUTICS, 2001, 23 (05) : 660 - 679
[28] Sevoflurance: A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia (vol 51, pg 660, 1996)
Patel, SS
Goa, KL
DRUGS, 1996, 52 (02) : 253 - 253
[29] Prednicarbate - A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders
Spencer, CM
Wagstaff, AJ
BIODRUGS, 1998, 9 (01) : 61 - 86
[30] PrednicarbateA Review of its Pharmacological Properties and Therapeutic Use in the Treatment of Dermatological Disorders
Caroline M. Spencer
Antona J. Wagstaff
BioDrugs, 1998, 9 : 61 - 86

← 1 2 3 4 5 →